HANGZHOU TIGERMED CONSULTING CO LTD
(HKEX: 3347)

Hangzhou Tigermed Consulting Co., Ltd. provides clinical research services for research and development of domestic and foreign pharmaceutical and health related products. Its services include technical services for phase I to phase IV clinical trials, registration and declaration of clinical trials, on-site services, as well as data management and analysis, etc. The company was founded on December 15, 2004 and is headquartered in Hangzhou, China.

32.250 -

-0.250 (-0.77%)
Range 32.200 - 32.950   (2.33%)
Open 32.200
Previous Close 32.500
Bid Price 32.250
Bid Volume ('000) 5.1
Ask Price 32.300
Ask Volume ('000) 0.7
Volume ('000) 629.8
Value 20,449,727
Remark -
Delayed prices. Updated at 20 Dec 2024 16:08.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis